Remikiren

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Remikiren
Remikiren.svg
Clinical data
ATC code
Legal status
Legal status
  • Investigational
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
Formula C33H50N4O6S
Molar mass 630.839 g/mol
3D model (JSmol)
  (verify)

Remikiren is a renin inhibitor under development for the treatment of hypertension (high blood pressure). It was first developed by Hoffmann–La Roche in 1996.[1]

References[edit]

  1. ^ Richter WF, Whitby BR, Chou RC (1996). "Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals". Xenobiotica. 26 (3): 243–54. PMID 8730917. doi:10.3109/00498259609046705.